At 52 weeks, 100% of subjects (n=4) showed over 30% improvement in pain and function. No serious adverse events or dose-limiting toxicity were reported at 26 to 52 weeks. Ready to turn the market’s ...

Please provide your email address to receive an email when new articles are posted on . Short foot exercise to address intrinsic muscle weakness relieved patellofemoral pain and improved function and ...

People with elevated stress levels are more likely to experience a decline in cognitive function, a new study found, affecting their capacity to remember, concentrate and learn new things. Stress is ...